Tuesday, October 22, 2013

Medivation, Astellas prostate cancer drug meets trial goals (Reuters)


Medivation, Astellas prostate cancer drug meets trial goals (Reuters)

Share With Friends: Share on FacebookTweet ThisPost to Google-BuzzSend on GmailPost to Linked-InSubscribe to This Feed | Rss To Twitter | Industry - Health - Healthcare News, News Feeds and News via Feedzilla.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)